Sarcoidosis is a multi-system disease of unknown etiology characterized by the formation of
granulomas in various organs. It affects people of all ethnic backgrounds and occurs at any …

Cardiac sarcoidosis (CS) results from epithelioid cell granulomas infiltrating the myocardium
and predisposing to conduction disturbances, ventricular tachyarrhythmias, and heart …

Background The major reasons to treat sarcoidosis are to lower the morbidity and mortality
risk or to improve quality of life (QoL). The indication for treatment varies depending on …

Background: The diagnosis of sarcoidosis is not standardized but is based on three major
criteria: a compatible clinical presentation, finding nonnecrotizing granulomatous …

Background Sarcoidosis is a systemic disease characterized by significant clinical
heterogeneity. Although most frequently involving the lungs, sarcoidosis may affect any …

Aortic stenosis is characterized both by progressive valve narrowing and the left ventricular
remodeling response that ensues. The only effective treatment is aortic valve replacement …

Background—Although cardiac magnetic resonance (CMR) and positron emission
tomography (PET) detect different pathological attributes of cardiac sarcoidosis (CS), the …

This joint position paper illustrates the role and the correct use of echocardiography,
radionuclide imaging with 18F-fluorodeoxyglucose positron emission tomography …

Background There is no consensus regarding the relative prognostic value of cardiac MRI
and fluorodeoxyglucose (FDG) PET in cardiac sarcoidosis. Purpose To perform a systematic …

Aims Cardiac death is the leading cause of mortality in patients with sarcoidosis, yet cardiac
involvement often remains undetected. Cardiovascular magnetic resonance imaging (CMR) …